COMP <GO>
CORZ vs BAC // FORWARD P/E MULTIPLE
Core Scientific Inc. (NASDAQ) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: CORZ 2
— BAC 10
▲ FORWARD P/E MULTIPLE LEADER: BAC
LAST: $13.25 (-8.18%) • MKT CAP: $4.64B
forward-pe
29.0x
LAST: $50.01 (-2.21%) • MKT CAP: $357.61B
forward-pe
10.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CORZ VS. BAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CORZ | BAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 11.90% | 41.00% | -29.10 | BAC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 2.50% | -37.50 | BAC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -9.72% | 2.10% | -11.82 | BAC | /fcf-yield <GO> |
| Operating Margin | -60.00% | 32.90% | -92.90 | BAC | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 27.00% | -87.00 | BAC | /net-margins <GO> |
| Revenue Growth (YoY) | -37.50% | 6.80% | -44.30 | BAC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 0.45 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | BAC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 6.60% | +0.70 | BAC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.0 | 27.7 | +11.37 | CORZ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.12 | 0.90 | +0.22 | CORZ | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 29.0x | 10.9x | +18.10 | BAC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.64B | $357.61B | -$352.97B | BAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CORZ REV | BAC REV | CORZ GROSS % | BAC GROSS % | CORZ FCF | BAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $319.0M | $113.10B | 11.9% | 44.0% | -$450.8M | $7.52B |
| FY 2024 | $510.7M | $105.86B | 23.7% | 44.0% | -$52.1M | -$13.57B |
| FY 2023 | $502.4M | $102.77B | 44.0% | 44.0% | $42.5M | $40.36B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CORZ // BETA 1.12
BAC // BETA 0.90